Pharsight

ASTRAZENECA AB patents facing oppositions

Top patents of ASTRAZENECA AB facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2056832B1 22 Mar, 2017 Compositions, suitable for oral administration, comprising a triazolo [4, 5-d]pyrimidin derivate Aug, 2027 3
EP3769781B1 19 Apr, 2023 Stable anti-ifnar1 formulation Aug, 2036 1
EP3142661B1 06 Oct, 2021 Method for suppressing glucagon secretion of an sglt2 inhibitor May, 2035 1